Cargando…
Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
SIMPLE SUMMARY: The comprehensive treatment of using neoadjuvant laparoscopic HIPEC and bidirectional chemotherapy before cytoreductive surgery has been introduced. We reported the real benefit of this strategy and analyze the prognostic factors on outcome. We also provided a recommended patient sel...
Autores principales: | Yu, Hsin-Hsien, Yonemura, Yutaka, Ng, Hui-Ji, Lee, Ming-Che, Su, Bor-Chyuan, Hsieh, Mao-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341196/ https://www.ncbi.nlm.nih.gov/pubmed/37444511 http://dx.doi.org/10.3390/cancers15133401 |
Ejemplares similares
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center
por: Yu, Hsin-Hsien, et al.
Publicado: (2017) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
por: Roh, Seung Jae, et al.
Publicado: (2020) -
The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021)